Miroculus

Miroculus, Inc. is a biotechnology company specializing in non-invasive molecular data gathering and analysis tools. Founded in 2014 and based in San Francisco, the company focuses on developing a digital microfluidics platform that automates and miniaturizes genomic protocols, such as next-generation sequencing (NGS) library preparation and synthetic biology. This innovative system provides assay flexibility and integrates seamlessly into existing laboratory workflows, offering clients—ranging from academic institutions to pharmaceutical and diagnostics companies—the ability to detect and monitor diseases at the molecular level. Miroculus's technology emphasizes affordability and accessibility, allowing medical practitioners to conduct accurate and minimally invasive molecular testing using low-cost cartridge-based solutions.